查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1442902

免疫疗法药物市场 - 2023-2031 年全球产业分析、规模、份额、成长、趋势和预测

Immunotherapy Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 168 Pages | 商品交期: 2-10个工作天内

价格

免疫治疗药物市场 - 报告范围

TMR 关于全球免疫疗法药物市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球免疫疗法药物市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球免疫疗法药物市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解免疫治疗药物市场。

该报告深入探讨了全球免疫疗法药物市场的竞争格局。全球免疫疗法药物市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球免疫疗法药物市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态

第 5 章：关键见解

  • 管道分析
  • 重要产业活动
  • COVID-19 影响分析

第 6 章：全球市场分析与预测：按药物类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按药物类型，2017-2031
    • 单株抗体
    • 免疫调节剂
    • 细胞疗法
    • 其他（疫苗等）
  • 市场吸引力分析：按药品类型

第 7 章：全球市场分析与预测：按治疗领域

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依治疗领域，2017-2031
    • 癌症
    • 自体免疫疾病
    • 传染性疾病
    • 其他的
  • 市场吸引力分析：按治疗领域

第 8 章：全球市场分析与预测：按配销通路

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2017-2031
    • 零售药局
    • 网路药局
    • 医院药房

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第15章：竞争格局

  • 全球市场，公司股票分析（2022 年）
  • 公司简介
    • Bristol Myers Squibb
    • Merck KGaA, Inc.
    • Novartis AG
    • AstraZeneca
    • Pfizer
    • Amgen
    • Gilead Sciences
    • Regeneron Pharmaceuticals Inc.
    • F. Hoffmann-La Roche AG
    • Eli Lilly and Company
Product Code: TMRGL23771

Immunotherapy Drugs Market - Scope of Report

TMR's report on the global immunotherapy drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global immunotherapy drugs market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global immunotherapy drugs market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the immunotherapy drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global immunotherapy drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global immunotherapy drugs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global immunotherapy drugs market.

The report delves into the competitive landscape of the global immunotherapy drugs market. Key players operating in the global immunotherapy drugs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global immunotherapy drugs market profiled in this report.

Key Questions Answered in Global immunotherapy drugs Market Report:

  • What is the sales/revenue generated by immunotherapy drugs across all regions during the forecast period?
  • What are the opportunities in the global immunotherapy drugs market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Immunotherapy Drugs Market - Research Objectives and Research Approach

The comprehensive report on the global immunotherapy drugs market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global immunotherapy drugs market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global immunotherapy drugs market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Immunotherapy Drugs Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
    • 4.3.4. Global Immunotherapy Drugs Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Industry Events
  • 5.3. COVID-19 Impact Analysis

6. Global Immunotherapy Drugs Market Analysis and Forecast, by Drug Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Drug Type, 2017-2031
    • 6.3.1. Monoclonal Antibodies
    • 6.3.2. Immunomodulators
    • 6.3.3. Cell Therapy
    • 6.3.4. Others (Vaccines, etc.)
  • 6.4. Market Attractiveness Analysis, by Drug Type

7. Global Immunotherapy Drugs Market Analysis and Forecast, by Therapy Area

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Therapy Area, 2017-2031
    • 7.3.1. Cancer
    • 7.3.2. Autoimmune Diseases
    • 7.3.3. Infectious Diseases
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Therapy Area

8. Global Immunotherapy Drugs Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Retail Pharmacies
    • 8.3.2. Online Pharmacies
    • 8.3.3. Hospital Pharmacies

9. Global Immunotherapy Drugs Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Immunotherapy Drugs Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Drug Type, 2017-2031
    • 10.2.1. Monoclonal Antibodies
    • 10.2.2. Immunomodulators
    • 10.2.3. Cell Therapy
    • 10.2.4. Others (Vaccines, etc.)
  • 10.3. Market Value Forecast, by Therapy Area, 2017-2031
    • 10.3.1. Cancer
    • 10.3.2. Autoimmune Diseases
    • 10.3.3. Infectious Diseases
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.4.1. Retail Pharmacies
    • 10.4.2. Online Pharmacies
    • 10.4.3. Hospital Pharmacies
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Drug Type
    • 10.5.2. By Therapy Area
    • 10.5.3. By Distribution Channel
    • 10.5.4. By Country

11. Europe Immunotherapy Drugs Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Drug Type, 2017-2031
    • 11.2.1. Monoclonal Antibodies
    • 11.2.2. Immunomodulators
    • 11.2.3. Cell Therapy
    • 11.2.4. Others (Vaccines, etc.)
  • 11.3. Market Value Forecast, by Therapy Area, 2017-2031
    • 11.3.1. Cancer
    • 11.3.2. Autoimmune Diseases
    • 11.3.3. Infectious Diseases
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.4.1. Retail Pharmacies
    • 11.4.2. Online Pharmacies
    • 11.4.3. Hospital Pharmacies
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Drug Type
    • 11.6.2. By Therapy Area
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Immunotherapy Drugs Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Drug Type, 2017-2031
    • 12.2.1. Monoclonal Antibodies
    • 12.2.2. Immunomodulators
    • 12.2.3. Cell Therapy
    • 12.2.4. Others (Vaccines, etc.)
  • 12.3. Market Value Forecast, by Therapy Area, 2017-2031
    • 12.3.1. Cancer
    • 12.3.2. Autoimmune Diseases
    • 12.3.3. Infectious Diseases
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.4.1. Retail Pharmacies
    • 12.4.2. Online Pharmacies
    • 12.4.3. Hospital Pharmacies
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Drug Type
    • 12.6.2. By Therapy Area
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Immunotherapy Drugs Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Drug Type, 2017-2031
    • 13.2.1. Monoclonal Antibodies
    • 13.2.2. Immunomodulators
    • 13.2.3. Cell Therapy
    • 13.2.4. Others (Vaccines, etc.)
  • 13.3. Market Value Forecast, by Therapy Area, 2017-2031
    • 13.3.1. Cancer
    • 13.3.2. Autoimmune Diseases
    • 13.3.3. Infectious Diseases
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.4.1. Retail Pharmacies
    • 13.4.2. Online Pharmacies
    • 13.4.3. Hospital Pharmacies
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Drug Type
    • 13.6.2. By Therapy Area
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Immunotherapy Drugs Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Drug Type, 2017-2031
    • 14.2.1. Monoclonal Antibodies
    • 14.2.2. Immunomodulators
    • 14.2.3. Cell Therapy
    • 14.2.4. Others (Vaccines, etc.)
  • 14.3. Market Value Forecast, by Therapy Area, 2017-2031
    • 14.3.1. Cancer
    • 14.3.2. Autoimmune Diseases
    • 14.3.3. Infectious Diseases
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.4.1. Retail Pharmacies
    • 14.4.2. Online Pharmacies
    • 14.4.3. Hospital Pharmacies
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Drug Type
    • 14.6.2. By Therapy Area
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Global Immunotherapy Drugs Market, Company Share Analysis (2022)
  • 15.2. Company Profiles
    • 15.2.1. Bristol Myers Squibb
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Product Portfolio
      • 15.2.1.3. Financial Overview
      • 15.2.1.4. SWOT Analysis
      • 15.2.1.5. Strategic Overview
    • 15.2.2. Merck KGaA, Inc.
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Product Portfolio
      • 15.2.2.3. Financial Overview
      • 15.2.2.4. SWOT Analysis
      • 15.2.2.5. Strategic Overview
    • 15.2.3. Novartis AG
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Product Portfolio
      • 15.2.3.3. Financial Overview
      • 15.2.3.4. SWOT Analysis
      • 15.2.3.5. Strategic Overview
    • 15.2.4. AstraZeneca
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Product Portfolio
      • 15.2.4.3. Financial Overview
      • 15.2.4.4. SWOT Analysis
      • 15.2.4.5. Strategic Overview
    • 15.2.5. Pfizer
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Product Portfolio
      • 15.2.5.3. Financial Overview
      • 15.2.5.4. SWOT Analysis
      • 15.2.5.5. Strategic Overview
    • 15.2.6. Amgen
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Product Portfolio
      • 15.2.6.3. Financial Overview
      • 15.2.6.4. SWOT Analysis
      • 15.2.6.5. Strategic Overview
    • 15.2.7. Gilead Sciences
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Product Portfolio
      • 15.2.7.3. Financial Overview
      • 15.2.7.4. SWOT Analysis
      • 15.2.7.5. Strategic Overview
    • 15.2.8. Regeneron Pharmaceuticals Inc.
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Product Portfolio
      • 15.2.8.3. Financial Overview
      • 15.2.8.4. SWOT Analysis
      • 15.2.8.5. Strategic Overview
    • 15.2.9. F. Hoffmann-La Roche AG
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Product Portfolio
      • 15.2.9.3. Financial Overview
      • 15.2.9.4. SWOT Analysis
      • 15.2.9.5. Strategic Overview
    • 15.2.10. Eli Lilly and Company
      • 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.10.2. Product Portfolio
      • 15.2.10.3. Financial Overview
      • 15.2.10.4. SWOT Analysis
      • 15.2.10.5. Strategic Overview

List of Tables

  • Table 01: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 02: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031
  • Table 03: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 07: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031
  • Table 08: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 09: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 11: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031
  • Table 12: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 15: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031
  • Table 16: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 17: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 19: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031
  • Table 20: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 21: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 23: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031
  • Table 24: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Immunotherapy Drugs Market Value Share, by Region, 2022
  • Figure 03: Global Immunotherapy Drugs Market Value Share, by Drug Type, 2022
  • Figure 04: Global Immunotherapy Drugs Market Value Share, by Therapy Area, 2022
  • Figure 05: Global Immunotherapy Drugs Market Value Share, by Distribution Channel, 2022
  • Figure 06: Global Immunotherapy Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 07: Global Immunotherapy Drugs Market Value Share Analysis, by Drug Type, 2022
  • Figure 08: Global Immunotherapy Drugs Market Value Share Analysis, by Drug Type, 2031
  • Figure 09: Global Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 10: Global Immunotherapy Drugs Market Value (US$ Mn), by Monoclonal Antibodies, 2017-2031
  • Figure 11: Global Immunotherapy Drugs Market Value Share Analysis, by Monoclonal Antibodies, 2022 and 2031
  • Figure 12: Global Immunotherapy Drugs Market Value (US$ Mn), by Immunomodulators, 2017-2031
  • Figure 13: Global Immunotherapy Drugs Market Value Share Analysis, by Immunomodulators, 2022 and 2031
  • Figure 14: Global Immunotherapy Drugs Market Value (US$ Mn), by Cell Therapy, 2017-2031
  • Figure 15: Global Immunotherapy Drugs Market Value Share Analysis, by Cell Therapy, 2022 and 2031
  • Figure 16: Global Immunotherapy Drugs Market Value (US$ Mn), by Others, 2017-2031
  • Figure 17: Global Immunotherapy Drugs Market Value Share Analysis, by Others, 2022 and 2031
  • Figure 18: Global Immunotherapy Drugs Market Value Share Analysis, by Therapy Area, 2022 and 2031
  • Figure 19: Global Immunotherapy Drugs Market Value Share Analysis, by Therapy Area, 2022
  • Figure 20: Global Immunotherapy Drugs Market Value Analysis, by Therapy Area, 2031
  • Figure 21: Global Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023-2031
  • Figure 22: Global Immunotherapy Drugs Market Value (US$ Mn), by Cancer, 2017-2031
  • Figure 23: Global Immunotherapy Drugs Market Value Share Analysis, by Cancer, 2022 and 2031
  • Figure 24: Global Immunotherapy Drugs Market Value (US$ Mn), by Autoimmune Diseases, 2017-2031
  • Figure 24: Global Immunotherapy Drugs Market Value Share Analysis, by Autoimmune Diseases, 2022 and 2031
  • Figure 25: Global Immunotherapy Drugs Market Value (US$ Mn), by Autoimmune Diseases, 2017-2031
  • Figure 25: Global Immunotherapy Drugs Market Value Share Analysis, by Autoimmune Diseases, 2022 and 2031
  • Figure 26: Global Immunotherapy Drugs Market Value (US$ Mn), by Others, 2017-2031
  • Figure 27: Global Immunotherapy Drugs Market Value Share Analysis, by Others, 2022 and 2031
  • Figure 28: Global Immunotherapy Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 29: Global Immunotherapy Drugs Market Value Share Analysis, by Distribution Channel, 2022
  • Figure 30: Global Immunotherapy Drugs Market Value Share Analysis, by Distribution Channel, 2031
  • Figure 31: Global Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 32: Global Immunotherapy Drugs Market Value (US$ Mn), by Retail Pharmacies, 2017-2031
  • Figure 33: Global Immunotherapy Drugs Market Value Share Analysis, by Retail Pharmacies, 2022 and 2031
  • Figure 34: Global Immunotherapy Drugs Market Value (US$ Mn), by Online Pharmacies, 2017-2031
  • Figure 35: Global Immunotherapy Drugs Market Value Share Analysis, by Online Pharmacies, 2022 and 2031
  • Figure 36: Global Immunotherapy Drugs Market Value (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 36: Global Immunotherapy Drugs Market Value Share Analysis, by Hospital Pharmacies, 2022 and 2031
  • Figure 37: Global Immunotherapy Drugs Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 38: Global Immunotherapy Drugs Market Value Share Analysis, by Region, 2022
  • Figure 39: Global Immunotherapy Drugs Market Value Analysis, by Region, 2031
  • Figure 40: Global Immunotherapy Drugs Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 41: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 42: North America Immunotherapy Drugs Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 43: North America Immunotherapy Drugs Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 44: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031
  • Figure 45: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022
  • Figure 46: North America Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 47: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031
  • Figure 48: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022
  • Figure 49: North America Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023-2031
  • Figure 50: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 51: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022
  • Figure 52: North America Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 53: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 54: Europe Immunotherapy Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Europe Immunotherapy Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031
  • Figure 57: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022
  • Figure 58: Europe Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 59: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031
  • Figure 60: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022
  • Figure 61: Europe Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023-2031
  • Figure 62: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 63: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022
  • Figure 64: Europe Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 65: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 66: Asia Pacific Immunotherapy Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 67: Asia Pacific Immunotherapy Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 68: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031
  • Figure 69: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022
  • Figure 70: Asia Pacific Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 71: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031
  • Figure 72: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022
  • Figure 73: Asia Pacific Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023-2031
  • Figure 74: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 75: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022
  • Figure 76: Asia Pacific Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 77: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 78: Latin America Immunotherapy Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 79: Latin America Immunotherapy Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 80: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031
  • Figure 81: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022
  • Figure 82: Latin America Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 83: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031
  • Figure 84: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022
  • Figure 85: Latin America Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023-2031
  • Figure 86: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 87: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022
  • Figure 88: Latin America Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 89 Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 90: Middle East & Africa Immunotherapy Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 91: Middle East & Africa Immunotherapy Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 92: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031
  • Figure 93: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022
  • Figure 94: Middle East & Africa Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 95: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031
  • Figure 96: Middle East & Africa Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023-2031
  • Figure 97: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022
  • Figure 98: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 99: Middle East & Africa Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 100: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022